Clinical Trial Update: Clinical Trial of Sintilimab Combined With Gemcitabine/Carboplatin Regimen in the Treatment of Advanced Primary Pulmonary Lymphoepithelioma-like Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sintilimab with gemcitabine/carboplatin for advanced primary pulmonary lymphoepithelioma-like carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Pulmonary Lymphoepithelioma-like Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)
• Sintilimab (sintilimab)

Snippet

Sponsor: Zhou Chengzhi | Conditions: Primary Pulmonary Lymphoepithelioma-like Carcinoma, Lung Cancer | Phase 2 | Status: UNKNOWN